GlaxoSmithKline recalls over half-million inhalers in U.S.


ATLANTA, Ga. (CBS46) – Pharmaceutical company GlaxoSmithKline says it is recalling more than 593,000 asthma inhalers due to a defect. reports the defect in the inhalers causes them to administer fewer doses of medicine than indicated.

The company is taking the Ventolin inhalers off the shelves, following the voluntary Level 2 recall, which affects only products in the United States. The inhalers were manufactured at the company’s plant in Zebulon, North Carolina.

The defect is not dangerous to patients.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s